The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Electronic Device Uses Pulses to Reduce Rheumatoid Arthritis Pain
Rheumatoid arthritis pain has been alleviated in half of patients enrolled in a study which used an electrical implanted device to emit magnetic pulses at the Academic Medical Center in Amsterdam, the Netherlands.
Rheumatologists! Unite Against the Formulary Police!
February 24th 2015Prior authorizations have begun to spread pandemic-like from high-cost biologics to treatments used routinely in rheumatology. The time burden on rheumatologists is insupportable, contends the author, who says it's time to take action.
Researchers Identify Potential Protein Triggers of Psoriasis
February 20th 2015Researchers have reportedly identified several proteins that are highly prevalent in human psoriasis and may play an important role in the development and progression of the disease and its co-morbidities and complications, including psoriatic arthritis.
Misdiagnosis Likely Due to Virus, Rheumatoid Arthritis Symptom Overlap
February 17th 2015Due to overlapping clinical and immunologic features between Chikungunya virus and rheumatoid arthritis' (RA) symptoms, Washington University in St. Louis researchers warn rheumatologists to be alert for potential misdiagnoses.
Canadian Rheumatologists Create Their List of Tests to "Choose Wisely"
February 14th 2015Antinuclear antibody testing and DEXA both appear on a new Canadian list of rheumatology tests to avoid and on a similar 2013 list from the American College of Rheumatology. There are interesting differences in the other 3 choices.
Adding Topical Corticosteroids to a Regimen of Etanercept in Patients with Plaque Psoriasis
February 13th 2015The addition of a topical corticosteroid to once-weekly etanercept produces similar outcomes among patients with moderate to severe plaque psoriasis as a regimen of twice weekly etanercept at the same dose.
Tocilizumab Safe for Treatment of Rheumatoid Arthritis in Patients with Renal Insufficiency
A clinical trial that evaluated the use of tocilizumab for the treatment of patients with rheumatoid arthritis and renal insufficiency found the medication to be safe and effective.
Early Rheumatoid Arthritis May Benefit from Disappearance of Anti-Citrullinated Peptide Antibodies
For early rheumatoid arthritis, the disappearance of particular anti-citrullinated peptide antibodies (ACPA) may be beneficial, according to findings published in Annals of the Rheumatic Diseases.
Starting NSAIDs May Be Riskier for Some With AS and SpA
February 10th 2015Patients with spondyloarthropathy may have increased risks for adverse events when starting NSAIDs for the first time, a registry study suggests. But doctors' caution in using these drugs among patients with comorbidities made the analysis complex.